Searched for
ORAL DEURUXOLITINIB
Sun Pharma’s baldness drug Leqselvi debuts in US market after patent dispute settledSun Pharmaceutical Industries has reached a settlement agreement with Incyte Corporation concerning Leqselvi, a drug for severe hair loss, ...- Sun Pharma shares in focus following US launch of LEQSELVITM, settlement with Incyte CorporationSun Pharma shares: In a regulatory filing on Monday, Sun Pharma announced that it has reached a settlement and licensing agreement with Inc...
- US court lifts restrictions on Sun Pharma launching autoimmune disorder drugSun Pharmaceutical Industries Ltd announced that a US court has ruled in its favour, immediately vacating a preliminary injunction that res...
- Sun Pharma gets US FDA nod for its specialty drug against baldnessSun Pharma announced FDA approval of Leqselvi (deuruxolitinib) 8 mg tablets for severe alopecia areata, marking a major milestone after acq...
- Sun Pharma files new drug application with USFDA for investigational medicine to treat alopeciaThe new drug application filing for deuruxolitinib with the USFDA is based on two pivotal Phase III trials, which included over 1,200 patie...
- Sun Pharma to buy concert for $576 mConcert has pioneered the use of deuterium (a hydrogen isotope) in medicinal chemistry and has an extensive patent portfolio, including its...
Load More